IndraLab

Statements


| 1

sparser
"We found that BMP-2 treatment at 12, 24, and 48 hours increased the active form of nuclear β-catenin protein levels (Figure xref ), decreased phospho-β-catenin protein levels (Figure xref ), and significantly upregulated LRP-5 mRNA and protein expression, but not LRP-6 ( P < 0.05; Figure xref and xref )."